Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 268.42x is 128% above its 5-year average of -949.57x, near the high end of its 5-year range (-2814.00x–268.42x).
As of the fiscal period ended Friday, December 31, 2021.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2021 (2021-12-31): 268.42x.
INTEREST COVERAGE RATIO
268.42x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
-949.57x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+128.27%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
+4310.56%
vs the sector median at left
Sol-Gel Technologies Ltd.
Market Cap
$244.55M
Interest Coverage Ratio
268.42x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
-949.57x
Market Cap
$245.36M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$246.29M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.35M
Interest Coverage Ratio
-2.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$242.31M
Interest Coverage Ratio
0.57x
TTM Avg
0.57x
3Y Avg
0.57x
5Y Avg
0.57x
Market Cap
$242.28M
Interest Coverage Ratio
15.37x
TTM Avg
15.37x
3Y Avg
15.37x
5Y Avg
15.37x
Market Cap
$248.70M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.40M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$238.06M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sol-Gel Technologies Ltd. (SLGL) | $244.55M | 268.42x | N/A | N/A | -949.57x |
| Century Therapeutics, Inc. (IPSC)vs › | $245.36M | N/A | N/A | N/A | N/A |
| Quantum-Si incorporated (QSI)vs › | $246.29M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | -2.74x | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.31M | 0.57x | 0.57x | 0.57x | 0.57x |
| Q32 Bio Inc. (QTTB)vs › | $242.28M | 15.37x | 15.37x | 15.37x | 15.37x |
| Upstream Bio, Inc. (UPB)vs › | $248.70M | N/A | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $239.40M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $238.06M | -1.08x | 0.39x | 0.39x | 0.20x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.36M | 0.97x | 0.97x | 0.97x | 0.97x |
Interest Coverage
268.4x
Debt/Equity
0.02
Current Ratio
10.37
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-12-31 | 268.42x |
| 2017-03-31 | -2814.00x |
| 2016-12-31 | -303.13x |
| 2016-09-30 | -1231.33x |
